Drugs / ampicillin/sulbactam
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT00879190 Comparator | May 2009 → Jun 2012 | chorioamnionitis | Stanford University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ampicillin/sulbactam | “Unasyn (ampicillin/sulbactam)” NCT00879190 ↗ |
| Known as | Unasyn | “Unasyn (ampicillin/sulbactam)” NCT00879190 ↗ |
| Route | Intravenous | “Unasyn 3 grams intravenously” NCT00879190 ↗ |